Centessa Pharma hoping for $250M IPO to top January series A and fund initial drug development

Retrieved on: 2021-05-24 15:00:00

Tags for this article:

Click the tags to see associated articles and topics

Centessa Pharma hoping for $250M IPO to top January series A and fund initial drug development. View article details on hiswai:

Excerpt

The biotechnology industry has embraced this philosophy to successfully advance medicines for patients,” wrote CEO Saurabh Saha, M.D., Ph.D., ...

Article found on: www.fiercebiotech.com